NKTT120
NKTT 120 is a humanized monoclonal antibody against the iNKT cells. NKTT 120 is promising for research of sickle cell disease (SCD) [1].
Product Specifications
UNSPSC
12352100
Target
Others
Related Pathways
Others
Field of Research
Cardiovascular Disease
References & Citations
[1]Majerus E M, et al. NKTT120 reduces iNKT cells without dose limiting toxicity in stable adult sickle cell patients in a phase 1 trial[J]. Blood, 2014, 124 (21) : 2718.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV768855 1.0 µg DNA
MIR4428 Lentiviral Vector (Human) (UbC) (pLenti-GIII-UbC)
Sign In for Pricing
View Details 
435249-01 25 mg
5-Bromo-2- (dimethoxymethyl) -1- (phenylsulfonyl) -1h-pyrrolo[2,3-b]pyridine
Sign In for Pricing
View Details 435249-02 50 mg
5-Bromo-2- (dimethoxymethyl) -1- (phenylsulfonyl) -1h-pyrrolo[2,3-b]pyridine
Sign In for Pricing
View Details